Prostaglandins
Products for Prostaglandins
- Cat.No. Product Name Information
-
GC41431
δ12-Prostaglandin D2
Δ12PGD2
Prostaglandin D2 (PGD2) is one of the five primary enzymatic prostaglandins derived directly from PGH2. -
GC41476
δ17-6-keto Prostaglandin F1α
ω3 6keto PGF2α
δ17-6-keto Prostaglandin F1α (δ17-6-keto PGF1α) is a cyclooxygenase (COX) product of eicosapentaenoic acid (EPA) in various tissues such as seminal vesicles, lung, Polymorphonuclear leukocytes, and ocular tissues. -
GC41617
(±)-α-Tocopherol
all-rac-α-Tocopherol, DL-α-Tocopherol
(±)-α-Tocopherol is a synthetic vitamin E, with antioxidation effect. -
GC49515
(±)-Ibuprofen-d3 (sodium salt)
DL-Ibuprofen-d3
An internal standard for the quantification of (±)-ibuprofen -
GC41315
(±)-Ketoprofen Glucuronide
rac-Ketoprofen Acyl-β-D-glucuronide, (R,S)-Ketoprofen Glucuronide
(±)-Ketoprofen glucuronide is a phase II metabolite of the non-steroidal anti-inflammatory drug (NSAID) ketoprofen.
-
GC45278
(±)-Ketoprofen-d3
(R,S)-Ketoprofen-d3, 2-(3-benzoylphenyl)Propionic Acid-d3
-
GC41685
(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively.
-
GC40271
(±)5(6)-DiHET MaxSpec® Standard
5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.
-
GC40281
(+)-15-epi Cloprostenol
DCloprostenol, (+)15(S)Cloprostenol
Cloprostenol is a synthetic prostaglandin F2α (PGF2α) analog and a potent FP receptor agonist. -
GC40282
(+)-5-trans Cloprostenol
DCloprostenol, (+)5,6trans Cloprostenol, (+)5trans16mchlorophenoxy tetranor PGF2α, (+)5trans16mchlorophenoxy tetranor Prostaglandin F2α
Cloprostenol is a synthetic derivative of prostaglandin F2α that is used in veterinary medicine as a luteolytic agent for the induction of estrus and in the treatment of reproductive disorders in cattle, swine, and horses. -
GC45255
(+)-5-trans Cloprostenol isopropyl ester
(+)-5-trans Cloprostenol isopropyl ester is a more lipid soluble form of (+)-5-trans cloprostenol , which is a less active form of the synthetic prostaglandin F2α (PGF2α) derivative cloprostenol .
-
GC45260
(+)-Cloprostenol isopropyl ester
(+)-5-cis Cloprostenol isopropyl ester, (+)16mchlorophenoxy tetranor Prostaglandin F2α isopropyl ester
(+)-Cloprostenol is a synthetic analog of prostaglandin F2α (PGF2α). -
GC45261
(+)-Cloprostenol methyl amide
DCloprostenol methyl amide, (+)16mChlorophenoxy tetranor PGF2α methyl amide
(+)-Cloprostenol is a synthetic analog of prostaglandin F2α (PGF2α). -
GC45262
(+)-Cloprostenol methyl ester
DCloprostenol methyl ester, (+)16mChlorophenoxy tetranor PGF2α methyl ester
(+)-Cloprostenol is a synthetic analog of prostaglandin F2α (PGF2α). -
GC40716
(R)-Butaprost
(±)15deoxy16Rhydroxy17cyclobutyl PGE1 methyl ester, 15deoxy16Rhydroxy17cyclobutyl PGE1 methyl ester, TR 4978
Butaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. -
GC41714
(R)-Butaprost (free acid)
(±)15deoxy16Rhydroxy17cyclobutyl PGE1, 15deoxy16Rhydroxy17cyclobutyl PGE1
Butaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. -
GC49179
(S)-O-Desmethyl Naproxen
(S)-6-Desmethyl Naproxen
A metabolite of (S)-naproxen -
GC20027
(±)5(6)-DiHET MaxSpec® Standard
(±)5,6-DiHETrE
5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.
-
GC41761
1-(6-Methoxy-2-naphthyl)ethanol
Naproxen Impurity K
1-(6-Methoxy-2-naphthyl)ethanol is a potential impurity in commercial preparations of naproxen. -
GC18235
1-O-Hexadecyl-sn-glycerol
α-Chimyl Alcohol, (S)-(+)-Chimyl Alcohol
1-O-Hexadecyl-sn-glycerol is a bioactive alkyl glyceryl ether.
-
GC49366
1-Salicylate Glucuronide
Salicyl Phenolic Glucuronide, Salicylic Acid Phenolic Glucuronide
A metabolite of salicylic acid and aspirin -
GC40577
11β-13,14-dihydro-15-keto Prostaglandin F2α
11β13,14dihydro15keto PGF2α, 11-epi-13,14-dihydro-15-keto PGF2α
11β-13,14-dihydro-15-keto Prostaglandin F2α (11β-13,14-dihydro-15-keto PGF2α) is a metabolite of Prostaglandin D2 (PGD2) in the 15-hydroxy PGDH pathway. -
GC46410
11β-13,14-dihydro-15-keto Prostaglandin F2α-d4
11β-13,14-dihydro-15-keto PGF2α-d4, 11-epi 13,14-dihydro-15-keto PGF2α-d4
A neuropeptide with diverse biological activities -
GC46411
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9
11β-13,14-dihydro-15-keto PGF2α-d9, 11-epi 13,14-dihydro-15-keto PGF2α-d9
A neuropeptide with diverse biological activities -
GC41243
11β-Misoprostol
Misoprostol is a widely sold analog of prostaglandin E1 (PGE1) which has potent but relatively non-selective agonist activity with respect to the prostanoid EP receptor subgroup.
-
GC41410
11β-Prostaglandin E2
11β-PGE2
11β-Prostaglandin E2 (11β-Dinoprostone), a Prostanoid derivative, inhibits [3H]PGE2 binding to hypothalamic membranes in the rat with a Ki of 53.3 nM. -
GC41432
11β-Prostaglandin F1β
9β,11βPGF1α, 11βPGF1β, 11epi PGF1β
11β-PGF1β is the stereoisomer of PGF1α with both C-9 and C-11 hydroxyls inverted. -
GC41404
11β-Prostaglandin F2α Ethanolamide
11-epi PGF2α-EA, 11β-PGF2α-EA, 11β-Prostamide F2α
11β-Prostaglandin F2α ethanolamide (11β-PGF2α-EA) is the theoretical hepatic metabolite of PGD2-EA, produced during COX-2 metabolism of the endogenous cannabinoid AEA which is found in brain, liver, and other mammalian tissues. -
GC46413
11β-Prostaglandin F2α-d9
9α,11β-PGF2α-d9, 11β-PGF2α-d9, 11-epi PGF2α-d9
A neuropeptide with diverse biological activities -
GC18634
11-deoxy Prostaglandin E1
11deoxy PGE1
11-deoxy Prostaglandin E1 (11-deoxy PGE1) is a synthetic analog of PGE1. -
GC41121
11-deoxy Prostaglandin E2
11deoxy PGE2
11-deoxy Prostaglandin E2 (11-deoxy PGE2) is a stable, synthetic analog of PGE2. -
GC41401
11-deoxy Prostaglandin F1α
11deoxy PGF1α
11-deoxy PGF1α is a synthetic analog of PGF1α. -
GC41402
11-deoxy Prostaglandin F1β
9β,11deoxy PGF1α, 11deoxy PGF1β
11-deoxy PGF1β is a synthetic analog of PGF1β. -
GC40274
11-deoxy Prostaglandin F2α
11deoxy PGF2α
11-deoxy PGF2α is a synthetic analog of PGF2α. -
GC40275
11-deoxy Prostaglandin F2β
11deoxy PGF2β
11-deoxy Prostaglandin F2β (11-deoxy PGF2β) is an analog of PGF2β. -
GC40335
11-deoxy-11-methylene Prostaglandin D2
11deoxy11methylene PGD2
Prostaglandin D2 is one of the five primary enzymatic prostaglandins derived directly from PGH2. -
GC41879
11-deoxy-11-methylene-15-keto Prostaglandin D2
11deoxy11methylene15keto PGD2
Prostaglandin D2 (PGD2) is one of the five primary enzymatic prostaglandins derived directly from PGH2. -
GC40390
11-deoxy-16,16-dimethyl Prostaglandin E2
11deoxy16,16dimethyl PGE2
11-deoxy-16,16-dimethyl PGE2 is a stable synthetic analog of PGE2. -
GC41880
11-keto Fluprostenol
Fluprostenol Prostaglandin D2
11-keto Fluprostenol is an analog of prostaglandin D2 (PGD2) with structural modifications intended to give it a prolonged half-life and greater potency. -
GC18617
11β-Prostaglandin E1
11βPGE1, 11epi PGE1
11β-Prostaglandin E1 (11β-PGE1) is an epimerized form of PGE1 at the C-11 position. -
GC18637
11β-Prostaglandin F2α
9α,11βPGF2α, 11βPGF2α, 11epi PGF2α
11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo.
-
GC41892
13(R),14(R)-epoxy Fluprostenol isopropyl ester
Epoxy Derivative 1, 13(R),14(R)epoxy Travoprost
Fluprostenol isopropyl ester is a potent F-series prostaglandin receptor agonist prodrug that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. -
GC41894
13(S),14(S)-epoxy Fluprostenol isopropyl ester
Epoxy Derivative 2, 13(S),14(S)epoxy Travoprost
Fluprostenol isopropyl ester is a potent F-series prostaglandin receptor agonist prodrug that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. -
GC40745
13,14-dehydro-15-cyclohexyl Carbaprostacyclin
13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2.
-
GC41433
13,14-dihydro Prostaglandin E1
PGE0, 13,14-dihydro PGE1
13,14-dihydro Prostaglandin E1 (13,14-dihydro PGE1) is a biologically active metabolite of PGE1 with comparable potency to the parent compound. -
GC46421
13,14-dihydro Prostaglandin E1-d4
13,14dh PGE1d4, Prostaglandin E0D4
A neuropeptide with diverse biological activities -
GC41902
13,14-dihydro Prostaglandin F1α
PGFα, 13,14dihydro PGF1α
13,14-dihydro PGF1α is a potential metabolite of PGF1α. -
GC41434
13,14-dihydro Prostaglandin F2α
13,14-dihydro PGF2α
13,14-dihydro Prostaglandin F2α (13,14-dihydro PGF2α) is the analog of PGF2α which has no unsaturation in the lower side chain.
-
GC41435
13,14-dihydro-15(R)-Prostaglandin E1
13,14dihydro15(R)PGE1
13,14-dihydro-15(R)-Prostaglandin E1 (13,14-dihydro-15(R)-PGE1) is an analog of 13,14-dihydro-PGE1 , which has the hydroxyl group at C-15 in the unnatural R configuration. -
GC41097
13,14-dihydro-15-keto Prostaglandin A2
13,14-dihydro-15-keto PGA2
PGE2 is metabolized rapidly to 13,14-dihydro-15-keto PGE2, which is present in the plasma of humans and other mammals. -
GC41098
13,14-dihydro-15-keto Prostaglandin A2 MaxSpec® Standard
Prostaglandin E2 is metabolized rapidly to 13,14-dihydro-15-keto PGE2, which is present in the plasma of humans and other mammals.
-
GC40578
13,14-dihydro-15-keto Prostaglandin D1
13,14dihydro15keto PGD1
Prostaglandin D1 (PGD1) is the theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. -
GC41411
13,14-dihydro-15-keto Prostaglandin D2
13,14-dihydro-15-keto PGD2
13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 which is formed through the 15-hydroxy PGDH pathway.
-
GC41412
13,14-dihydro-15-keto Prostaglandin D2 MaxSpec® Standard
13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 which is formed through the 15-hydroxy PGDH pathway.
-
GC46423
13,14-dihydro-15-keto Prostaglandin D2-d4
13,14dihydro15keto PGD2d4
A neuropeptide with diverse biological activities -
GC46424
13,14-dihydro-15-keto Prostaglandin D2-d9
13,14-dihydro-15-keto-PGD2-d9
A neuropeptide with diverse biological activities -
GC18783
13,14-dihydro-15-keto Prostaglandin E1
11α-Hydroxy-9,15-diketoprostanoic Acid, 15-keto-PGE0, 13,14-dihydro-15-keto PGE1, 15-keto-dihydro-PGE1, 15-keto Prostaglandin E0
13,14-dihydro-15-keto Prostaglandin E1 (PGE1) is a metabolite of PGE1 with much reduced biological activity. -
GC46425
13,14-dihydro-15-keto Prostaglandin E1-d4
13,14dh15k PGE1d4
A neuropeptide with diverse biological activities -
GC41413
13,14-dihydro-15-keto Prostaglandin E2
13,14-dihydro-15-keto PGE2
13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is the primary metabolite of PGE2 in plasma.
-
GC41414
13,14-dihydro-15-keto Prostaglandin E2 MaxSpec® Standard
13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) is the primary metabolite of PGE2 in plasma.
-
GC46426
13,14-dihydro-15-keto Prostaglandin E2-d4
13,14-dh-15-keto PGE2-d4, 13,14-dihydro-oxo-PGE2-d4, PGEM-d4
A neuropeptide with diverse biological activities -
GC46427
13,14-dihydro-15-keto Prostaglandin E2-d9
13,14-dihydro-15-keto PGE2-d9, 13,14-dihydro-oxo-PGE2-d9, PGEM-d9
A neuropeptide with diverse biological activities -
GC41436
13,14-dihydro-15-keto Prostaglandin F1α
13,14dihydro15keto PGF1α
13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been reported in the rat stomach. -
GC40579
13,14-dihydro-15-keto Prostaglandin F2α
13,14dihydro15keto PGF2α, PGFM
13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway. -
GC40580
13,14-dihydro-15-keto Prostaglandin F2α MaxSpec® Standard
13,14-dihydro-15-keto Prostaglandin F2α (13,14-dihydro-15-keto PGF2α) is the first prominent plasma metabolite of PGF2α in the 15-hydroxy PGDH pathway.
-
GC41099
13,14-dihydro-15-keto Prostaglandin J2
Various biological properties exist for both prostaglandin J2 (PGJ2) and its metabolites such as inhibition of platelet aggregation, antitumor, and antiviral activity.
-
GC40625
13,14-dihydro-15-keto-tetranor Prostaglandin D2
A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
-
GC40626
13,14-dihydro-15-keto-tetranor Prostaglandin E2
13,14-dihydro-15-keto-tetranor PGE2
A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. -
GC41903
13,14-dihydro-15-keto-tetranor Prostaglandin F1α
5β, 7αdihydroxy11ketotetranorProstanoic Acid, 9β13,14dihydro15ketotetranor Prostaglandin F1α, 9β,11αdihydroxy15oxo2,3,4,5tetranorProstanoic Acid
The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
-
GC41904
13,14-dihydro-15-keto-tetranor Prostaglandin F1β
5β, 7αdihydroxy11ketotetranorProstanoic Acid, 9β13,14dihydro15ketotetranor Prostaglandin F1α, 9β,11αdihydroxy15oxo2,3,4,5tetranorProstanoic Acid
13,14-dihydro-15-keto tetranor-Prostaglandin F1β is a major urinary metabolite of PGE2 that is excreted in guinea pig urine at a concentration range of 1.34-2.74 μg/kg. -
GC41905
13,14-dihydro-16,16-difluoro Prostaglandin E1
15hydroxy Lubiprostone
Prostaglandin E1 (PGE1) is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. -
GC46433
13,14-dihydro-19(R)-hydroxy Prostaglandin E1
19(R)hydroxy PGE0, 13,14dihydro19(R)hydroxy PGE1
A neuropeptide with diverse biological activities -
GC41906
13,14-epoxy Fluprostenol isopropyl ester
13,14epoxy Travoprost
Fluprostenol isopropyl ester is a potent F-series prostaglandin receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. -
GC40531
15(R),19(R)-hydroxy Prostaglandin E1
15(R),19(R)hydroxy PGE1
19(R)-Hydroxylated prostaglandins occur in μg/ml concentrations in the semen of certain mammalian species, especially primates. -
GC41472
15(R),19(R)-hydroxy Prostaglandin E2
15(R),19(R)hydroxy PGE2
19(R)-Hydroxylated prostaglandins occur in μg/ml concentrations in the semen of certain mammalian species, especially primates. -
GC41920
15(R),19(R)-hydroxy Prostaglandin F1α
15(R),19(R)hydroxy PGF1α
19(R)-Hydroxylated prostaglandins occur in μg/ml concentrations in the semen of certain mammalian species, especially primates. -
GC40532
15(R),19(R)-hydroxy Prostaglandin F2α
15(R),19(R)hydroxy PGF2α
19(R)-Hydroxylated prostaglandins (PGs) occur in μg/ml concentrations in the semen of certain mammalian species, especially primates. -
GC41921
15(R)-15-methyl Prostaglandin A2
15(R)15methyl PGA2
Arbaprostil (15(R)-15-methyl prostaglandin E2) is a synthetic prostaglandin E2 (PGE2) analog developed for its cytoprotective activity. -
GC41164
15(R)-15-methyl Prostaglandin D2
15(R)15methyl PGD2
15(R)-15-methyl Prostaglandin D2 (15(R)-15-methyl PGD2) is a metabolically stable synthetic analog of PGD2. -
GC41165
15(R)-15-methyl Prostaglandin E2
Arbaprostil, 15(R)15methyl PGE2
15(R)-15-methyl Prostaglandin E2 (15(R)-15-methyl PGE2) is a prodrug for the potent PGE2 analog 15(S)-15-methyl PGE2. -
GC41440
15(R)-15-methyl Prostaglandin F2α
15(R)15methyl PGF2α
15(R)-15-methyl PGF2α is a metabolically stable analog of PGF2α. -
GC41244
15(R)-15-methyl Prostaglandin F2α methyl ester
15(R)-Methyl carboprost, 15(R)15methyl PGF2α methyl ester
15(R)-15-methyl Prostaglandin F2α methyl ester (15(R)-15-methyl PGF2α methyl ester) is a lipid soluble prodrug form of 15(R)-15-methyl PGF2α with increased membrane permeability. -
GC40988
15(R)-17-phenyl trinor Prostaglandin F2α
15epi Bimatoprost (free acid), 15(R)Bimatoprost (free acid), 15(R)17phenyl trinor PGF2α
17-phenyl trinor Prostaglandin F2α N-ethyl amide (17-phenyl trinor PGF2α) is an F-series prostaglandin analog which has been approved for use as an ocular hypotensive drug, sold under the Allergan trade name 17-phenyl trinor PGF2α ethyl amide. -
GC40648
15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide
15(R)Bimatoprost, 15(R)17phenyl trinor PGF2α ethyl amide
15(R)-17-phenyl trinor Prostaglandin F2α ethyl amide (15(R)-17-phenyl trinor PGF2α ethyl amide) is an isomer of bimatoprost, characterized by an inverted (β) hydroxyl group at C-15. -
GC41922
15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester
15epi Bimatoprost isopropyl ester, 15(R)Bimatoprost isopropyl ester, 15(R)17phenyl trinor PGF2α isopropyl ester
15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester (15(R)-17-phenyl trinor PGF2α isopropyl ester) is the latanoprost-related isomer containing both a double bond at 13,14 and an inverted (β) hydroxyl group at C-15. -
GC41416
15(R)-Prostaglandin D2
15(R)PGD2
Many of the effects of prostaglandin D2 (PGD2) are transduced via a traditional 7-transmembrane GPCR, the DP1 receptor. -
GC41417
15(R)-Prostaglandin E2
15(R)PGE2, 15epi PGE2
15(R)-Prostaglandin E2 (15(R)-PGE2) is the C-15 epimer of the naturally occurring 15(S)-PGE2. -
GC46439
15(R)-Prostaglandin F1α
15(R)-PGF1α, 15-epi PGF1α
The C-15 epimer of PGF1α -
GC40581
15(R)-Prostaglandin F2α
15epi PGF2α
15(R)-PGF2α is the C-15 epimer of the naturally occurring mammalian autacoid PGF2α. -
GC41923
15(R)-Prostaglandin I2 (sodium salt)
15(R)-PGI2
15(R)-Prostaglandin I2 (15(R)-PGI2) is an isomer of the natural 15(S) prostanoid, PGI2. -
GC41166
15(S)-15-methyl Prostaglandin D2
15(S)15methyl PGD2
15(S)-15-methyl Prostaglandin D2 (15(S)-15-methyl PGD2) is a metabolically stable synthetic analog of PGD2. -
GC18767
15(S)-15-methyl Prostaglandin E1
15(S)15methyl PGE1
15(S)-15-methyl Prostaglandin E1 (15(S)-15-methyl PGE1) is a metabolically stable synthetic analog of PGE1 . -
GC41167
15(S)-15-methyl Prostaglandin E2
15(S)15methyl PGE2
15(S)-15-methyl PGE2 is a potent, metabolically stable analog of PGE2. -
GC41924
15(S)-15-methyl Prostaglandin F2α isopropyl ester
15(S)15methyl PGF2α isopropyl ester
15(S)-15-methyl Prostaglandin F2α (15(S)-15-methyl PGF2α) has been shown to have potent uterine stimulant and abortifacient properties when administered intramuscularly to induce labor. -
GC18372
15(S)-15-methyl Prostaglandin F2α methyl ester
Methyl carboprost, 15(S)15methyl PGF2α methyl ester, U36384
15(S)-15-methyl PGF2α methyl ester is a derivative of 15(S)-15-methyl PGF2α with increased membrane permeability. -
GC41226
15(S)-acetate Prostaglandin A2 methyl ester
15-acetyl PGA2 methyl ester, 15S-O-acetyl-PGA2 methyl ester, 15S-PGA2 methyl ester, 15-acetate
15(S)-acetate Prostaglandin A2 methyl ester is a 15-acetylated derivative of prostaglandin A2 methyl ester. -
GC40283
15(S)-Fluprostenol
(+)-15(R)-Fluprostenol isopropyl ester is a prodrug (Travoprost) which is converted by esterase enzymatic activity in the cornea to yield the corresponding free acid.
-
GC41589
15(S)-Fluprostenol isopropyl ester
15(S)FluIpr
15(S)-Fluprostenol isopropyl ester (15(S)-Flu-Ipr) is the unnatural C-15 epimer of Travoprost. -
GC41093
15(S)-Latanoprost
15epi Latanoprost
15(S)-Latanoprost is an analog of latanoprost in which the hydroxyl at carbon 15 is inverted relative to latanoprost. -
GC49036
15-(6-nitroxyhexanoyl)-17-phenyl trinor Prostaglandin F2α
15-(6-nitroxyhexanoyl)-17-phenyl trinor PGF2α, 15-(6-nitroxyhexanoyl)-Bimatoprost, NCX 470
A nitric oxide-donating derivative of 17-phenyl trinor prostaglandin F2α